Eleonora Arboscello

1.0k total citations
44 papers, 534 citations indexed

About

Eleonora Arboscello is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Eleonora Arboscello has authored 44 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Cardiology and Cardiovascular Medicine and 10 papers in Hematology. Recurrent topics in Eleonora Arboscello's work include Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Eleonora Arboscello is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Eleonora Arboscello collaborates with scholars based in Italy, United States and Switzerland. Eleonora Arboscello's co-authors include Paolo Spallarossa, Matteo Sarocchi, Pietro Ameri, Claudio Brunelli, Giacomo Tini, G Ghigliotti, Francesco Grossi, Giuseppina Novo, Gabriele Zoppoli and Paola Queirolo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Eleonora Arboscello

41 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleonora Arboscello Italy 14 237 210 83 81 74 44 534
Oscar Calvillo‐Argüelles Canada 12 280 1.2× 139 0.7× 75 0.9× 81 1.0× 61 0.8× 24 452
Ladislav Jebavý Czechia 14 223 0.9× 199 0.9× 57 0.7× 55 0.7× 130 1.8× 52 517
Gülten Tekuzman Türkiye 15 234 1.0× 334 1.6× 171 2.1× 59 0.7× 70 0.9× 58 737
Yoshiki Terada Japan 11 212 0.9× 196 0.9× 76 0.9× 34 0.4× 139 1.9× 42 573
Mika Nakamae Japan 12 183 0.8× 204 1.0× 67 0.8× 33 0.4× 280 3.8× 73 669
Elizabeth A. M. Feijen Netherlands 13 513 2.2× 203 1.0× 147 1.8× 62 0.8× 61 0.8× 28 836
Stacy Epstein United States 6 269 1.1× 108 0.5× 75 0.9× 24 0.3× 56 0.8× 10 444
Thomas R. Cochran United States 7 519 2.2× 144 0.7× 102 1.2× 74 0.9× 17 0.2× 9 738
Beáta Mladosievičová Slovakia 11 147 0.6× 112 0.5× 82 1.0× 23 0.3× 55 0.7× 61 399
Jan M. Horáček Czechia 15 273 1.2× 179 0.9× 60 0.7× 58 0.7× 106 1.4× 50 498

Countries citing papers authored by Eleonora Arboscello

Since Specialization
Citations

This map shows the geographic impact of Eleonora Arboscello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Arboscello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Arboscello more than expected).

Fields of papers citing papers by Eleonora Arboscello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Arboscello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Arboscello. The network helps show where Eleonora Arboscello may publish in the future.

Co-authorship network of co-authors of Eleonora Arboscello

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Arboscello. A scholar is included among the top collaborators of Eleonora Arboscello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Arboscello. Eleonora Arboscello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sartini, Stefano, et al.. (2024). The Role of Pocus in Acute Respiratory Failure: A Narrative Review on Airway and Breathing Assessment. Journal of Clinical Medicine. 13(3). 750–750. 3 indexed citations
2.
Orsi, Andrea, Bianca Bruzzone, Diego Ferone, et al.. (2021). On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic. Journal of Virological Methods. 295. 114201–114201. 18 indexed citations
3.
Tini, Giacomo, Pietro Ameri, Giulia Buzzatti, et al.. (2021). Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer. Frontiers in Cardiovascular Medicine. 8. 654728–654728. 7 indexed citations
4.
Biagio, Antonio Di, Roberta Della Bona, Antonio Vena, et al.. (2021). Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19.. PubMed. 18(5). 338–345. 12 indexed citations
6.
Spallarossa, Paolo, Matteo Sarocchi, Giacomo Tini, et al.. (2020). How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy. Frontiers in Pharmacology. 11. 972–972. 26 indexed citations
7.
Tini, Giacomo, Matteo Sarocchi, Giuliano Tocci, et al.. (2019). Arterial hypertension in cancer: The elephant in the room. International Journal of Cardiology. 281. 133–139. 51 indexed citations
8.
Cavo, Alessia, A. Rubagotti, Elisa Zanardi, et al.. (2018). Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes. Therapeutic Advances in Medical Oncology. 10. 1960360859–1960360859. 13 indexed citations
9.
Sarocchi, Matteo, Eleonora Arboscello, G Ghigliotti, et al.. (2018). Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction. Chemotherapy. 63(6). 315–320. 8 indexed citations
10.
Sarocchi, Matteo, Francesco Grossi, Eleonora Arboscello, et al.. (2018). Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients. The Oncologist. 23(8). 936–942. 66 indexed citations
11.
Spallarossa, Paolo, Claudio Brunelli, Eleonora Arboscello, et al.. (2017). Potential cardiac risk of immune‐checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects. Medicinal Research Reviews. 38(5). 1447–1468. 24 indexed citations
12.
Breccia, Massimo, Patrizia Pregno, Paolo Spallarossa, et al.. (2016). Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion. Annals of Hematology. 96(4). 549–558. 39 indexed citations
13.
Breccia, Massimo, Eleonora Arboscello, Gioia Colafigli, et al.. (2016). Proposal for a tailored stratification at baseline and monitoring of cardiovascular effects during follow-up in chronic phase chronic myeloid leukemia patients treated with nilotinib frontline. Critical Reviews in Oncology/Hematology. 107. 190–198. 10 indexed citations
14.
Balleari, Enrico, Marino Clavio, Eleonora Arboscello, et al.. (2011). Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes. Leukemia Research. 35(11). 1472–1476. 16 indexed citations
15.
Riccardi, Alessandro, et al.. (2008). Adenosine in the treatment of supraventricular tachycardia: 5 years of experience (2002-2006). The American Journal of Emergency Medicine. 26(8). 879–882. 25 indexed citations
16.
Schenone, Eva, et al.. (2002). Dexamethazone-induced Acute Tumor Lysis Syndrome in a T-cell Malignant Lymphoma. Leukemia & lymphoma. 43(5). 1129–1132. 20 indexed citations
17.
Pannacciulli, I, et al.. (1999). In vitro toxicity of taxol based anticancer drug combinations on human hemopoietic progenitors.. PubMed. 19(1A). 409–12. 6 indexed citations
18.
Ballarino, Paola, et al.. (1998). Toxicity on human hemopoietic progenitors of 2'-2'-difluoro-2'deoxycytidine (gemcitabine).. PubMed. 18(2A). 1037–42. 1 indexed citations
19.
Pannacciulli, I, et al.. (1998). Cisplatin inhibits erythroid committed progenitor (BFU‐E) mobilization in peripheral blood. European Journal Of Haematology. 61(1). 65–70. 1 indexed citations
20.
Ballarino, Paola, et al.. (1996). Interferon-α Inhibits CFU-GM Mobilization Following Chemotherapy and G-CSF Administration. Journal of Interferon & Cytokine Research. 16(11). 953–956. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026